Patents by Inventor Liana Horowitz

Liana Horowitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8298222
    Abstract: A method is disclosed for disrupting capillary blood flow and trapping materials such as chemotherapeutic agents in undesirable tissue, including cells of a cancerous or non-cancerous tumor. The method involves the placement of electrodes into or near the vicinity of capillary vessels supplying blood to capillaries in the undesirable tissue, and application of electrical pulses causing capillary blood flow disruption. In some cases, the electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body's immune system. The process may further comprise monitoring blood flow and/or infusion of a material such as a chemotherapeutic agent or marker into the blood.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: October 30, 2012
    Assignee: The Regents of the University of California
    Inventors: Boris Rubinsky, Jon Edd, Liana Horowitz
  • Publication number: 20090326436
    Abstract: A method is disclosed for disrupting capillary blood flow and trapping materials such as chemotherapeutic agents in undesirable tissue, including cells of a cancerous or non-cancerous tumor. The method involves the placement of electrodes into or near the vicinity of capillary vessels supplying blood to capillaries in the undesirable tissue, and application of electrical pulses causing capillary blood flow disruption. In some cases, the electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body's immune system. The process may further comprise monitoring blood flow and/or infusion of a material such as a chemotherapeutic agent or marker into the blood.
    Type: Application
    Filed: April 27, 2009
    Publication date: December 31, 2009
    Inventors: Boris Rubinsky, Jon Edd, Liana Horowitz
  • Publication number: 20080269586
    Abstract: A method for disrupting blood flow to undesirable tissue such as cells of a cancerous or non-cancerous tumor is disclosed. It involves the placement of electrodes into or near the vicinity of vessels supplying blood to the undesirable tissue and through the application of electrical pulses causing blood flow disruption. The electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body immune system. The process may further comprise monitoring blood flow and/or infusion of a material such as a chemotherapeutic agent or marker into the blood.
    Type: Application
    Filed: June 27, 2008
    Publication date: October 30, 2008
    Inventors: BORIS RUBINSKY, JON FRANCIS EDD, LIANA HOROWITZ
  • Publication number: 20050171523
    Abstract: A method of stopping or controlling bleeding by the placement of electrodes into or near the vicinity of vessels is disclosed. Then the application of electrical pulses causing irreversible electroporation of vessel and blood cells throughout the entire area of current flow the bleeding is stopped or controlled. The electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body immune system. Through the use of irreversible electroporation bleeding can be stopped or controlled without inducing thermal damage.
    Type: Application
    Filed: December 21, 2004
    Publication date: August 4, 2005
    Inventors: Boris Rubinsky, Jon Edd, Liana Horowitz
  • Publication number: 20050171574
    Abstract: A method for disrupting blood flow to undesirable tissue such as cells of a cancerous or non-cancerous tumor is disclosed. It involves the placement of electrodes into or near the vicinity of vessels supplying blood to the undesirable tissue and through the application of electrical pulses causing blood flow disruption. The electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body immune system. The process may further comprise monitoring blood flow and/or infusion of a material such as a chemotherapeutic agent or marker into the blood.
    Type: Application
    Filed: December 21, 2004
    Publication date: August 4, 2005
    Inventors: Boris Rubinsky, Jon Edd, Liana Horowitz